+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
Biopharmaceutical CMO Market Report 2026 - Product Thumbnail Image

Biopharmaceutical CMO Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 500 Pages +
  • Global
From
U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031 - Product Thumbnail Image

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

  • Drug Pipelines
  • February 2026
  • 3300 Pages
  • United States
From
Rare Kidney Diseases Market Report 2026 - Product Thumbnail Image

Rare Kidney Diseases Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator